Loading...
935106861
info@markelab.com
Precio
375€ (100 µg)
Utomilumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting TNFRSF9/CD137, Utomilumab is under investigation in clinical trial NCT03318900 (T Cell Immunotherapy for Advanced Ovarian Cancer).
Biosimilars
Human
Monoclonal
Human
TNFRSF9/CD137
Human
IgG2 Lambda
Unconjugated
Liquid
ELISA, WB
100 µg
1 mg
Recombinant
> 95%
Purified from cell culture supernatants by Protein A/G chromatography.
0.01 M PBS. pH 7.4.
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
No
Shipped within 7-12 working days.
Biosimilars
CAS Number 1417318-27-4
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más